Detection of thyroid malignancy in a hot nodule by fluorine-18- fluorodeoxyglucose positron emission tomography

Singapore Medical Journal

Volumn 46, Issue 6, 2005, Pages 304-307

  Low, S C S ^a   Sinha, A K ^a   Sundram, Felix X ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Positron emission tomography; Radionuclide imaging; Thyroid gland; Thyroid neoplasm; Thyroid nodule

Indexed keywords

CARBIMAZOLE; FLUORODEOXYGLUCOSE F 18; IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; ASPIRATION BIOPSY; BEAM THERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CASE REPORT; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; ECHOGRAPHY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; LUNG HILUS; NECK DISSECTION; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE THERAPY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROID NODULE; THYROID SCINTISCANNING; THYROIDECTOMY; THYROTOXICOSIS; WHOLE BODY SCINTISCANNING;

CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THYROID NEOPLASMS;

EID: 19944421430     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 1997; 26:777-800.
2. Mazzaferri EL, de los Santos ET, Rofagha-Keyhani S. Solitary thyroid nodule: diagnosis and management. Med Clin North Am 1988; 72:1177-211.
3. Corvilain B, Dumont JE, Vassart G. Toxic adenoma and toxic multinodular goiter. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000:564-72.
4. Kaplan MM. Evaluation of thyroid nodules by needle biopsy. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000:446.
5. DeGroot LJ, Larsen PR, Hennemann G. Thyrotoxicosis of other etiologies. In: The Thyroid and its Diseases. 6th ed. Philadelphia: Churchill Livingstone, 1996: 496.
6. Harach HR, Sanchez SS, Williams ED. Pathology of the autonomously functioning (hot) thyroid nodule. Ann Diag Pathol 2002; 6:10-9.
7. Daumerie C, Ayoubi S, Rahier J, Buysschaert M, Squifflet JP. [Prevalence of thyroid cancer in hot nodules.] Ann Chir 1998; 52:444-8. French.
8. Jastrzebska H, Gietka-Czernel M, Zgliczynski S. [Hormonal replacement therapy in women after surgery for thyroid cancer treated with suppressive doses of L-thyroxine.] Wiad Lek 2001; 54 Suppl 1:383-8. Polish.
9. Stocker DJ, Burch HB. Thyroid cancer yield in patients with Graves' disease. Minerva Endocrinol 2003; 28:205-12.
10. Adler LP, Bloom AD. Positron emission tomography of thyroid masses. Thyroid 1993; 3:195-200.
11. Bloom AD, Adler LP, Shuck JM. Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 1993; 114:728-35.
12. Reimer SE, Adler LP, Bloom AD. Prospective evaluation of PET FDG in FNA indeterminate thyroid nodules (abstract). J Nucl Med 1998; 39:123.
13. Uematsu H, Sadato N, Ohtsubo T, Tsuchida T, Nakamura S, Sugimoto K, et al. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. J Nucl Med 1998; 39:453-9.
14. Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001; 130:941-6.
15. Schoder H, Yeung HW. Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med 2004; 34:180-97.
16. Hooft L, Hoekstra OS, Deville W, Lips P, Teule GJ, Boers M, et al. Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. J Clin Endocrinol Metab 2001; 86:3779-86.
17. Joensuu H, Ahonen A. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose. J Nucl Med 1987; 28:910-4.
18. Grünwald F, Schomburg A, Bender H, Klemm E, Menzel C, Bultmann T, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1996; 23:312-9.